148 related articles for article (PubMed ID: 20926112)
1. Influence of an additional amino group on the potency of aminoadamantanes against influenza virus A. II - Synthesis of spiropiperazines and in vitro activity against influenza A H3N2 virus.
Fytas C; Kolocouris A; Fytas G; Zoidis G; Valmas C; Basler CF
Bioorg Chem; 2010 Dec; 38(6):247-51. PubMed ID: 20926112
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.
Zoidis G; Kolocouris N; Naesens L; De Clercq E
Bioorg Med Chem; 2009 Feb; 17(4):1534-41. PubMed ID: 19195900
[TBL] [Abstract][Full Text] [Related]
3. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
Göktaş F; Vanderlinden E; Naesens L; Cesur N; Cesur Z
Bioorg Med Chem; 2012 Dec; 20(24):7155-9. PubMed ID: 23117173
[TBL] [Abstract][Full Text] [Related]
4. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues.
Kolocouris A; Spearpoint P; Martin SR; Hay AJ; López-Querol M; Sureda FX; Padalko E; Neyts J; De Clercq E
Bioorg Med Chem Lett; 2008 Dec; 18(23):6156-60. PubMed ID: 18947998
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiviral activity evaluation of some aminoadamantane derivatives.
Kolocouris N; Foscolos GB; Kolocouris A; Marakos P; Pouli N; Fytas G; Ikeda S; De Clercq E
J Med Chem; 1994 Sep; 37(18):2896-902. PubMed ID: 8071937
[TBL] [Abstract][Full Text] [Related]
7. Influence of an additional 2-amino substituent of the 1-aminoethyl pharmacophore group on the potency of rimantadine against influenza virus A.
Tataridis D; Fytas G; Kolocouris A; Fytas C; Kolocouris N; Foscolos GB; Padalko E; Neyts J; De Clercq E
Bioorg Med Chem Lett; 2007 Feb; 17(3):692-6. PubMed ID: 17113287
[TBL] [Abstract][Full Text] [Related]
8. New adamantane derivatives can overcome resistance of influenza A(H1N1)pdm2009 and A(H3N2) viruses to remantadine.
Shibnev VA; Garaev TM; Finogenova MP; Shevchenko ES; Burtseva EI
Bull Exp Biol Med; 2012 Jun; 153(2):233-5. PubMed ID: 22816091
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2.
Kolocouris N; Kolocouris A; Foscolos GB; Fytas G; Neyts J; Padalko E; Balzarini J; Snoeck R; Andrei G; De Clercq E
J Med Chem; 1996 Aug; 39(17):3307-18. PubMed ID: 8765514
[TBL] [Abstract][Full Text] [Related]
10. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of bioactive adamantane spiro heterocycles.
Kolocouris N; Zoidis G; Foscolos GB; Fytas G; Prathalingham SR; Kelly JM; Naesens L; De Clercq E
Bioorg Med Chem Lett; 2007 Aug; 17(15):4358-62. PubMed ID: 17588747
[TBL] [Abstract][Full Text] [Related]
12. Novel N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives as potent and selective influenza virus fusion inhibitors.
Göktaş F; Özbil M; Cesur N; Vanderlinden E; Naesens L; Cesur Z
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900028. PubMed ID: 31531897
[TBL] [Abstract][Full Text] [Related]
13. Construction and synthesis of tricyclic matrinic derivatives against influenza A virus by privileged structure strategy.
Jiang J; Zhao X; Niu T; Yan H; Yinghong LI; Yuhuan LI; Song D; Tang S; Xing J
Pharmazie; 2019 May; 74(5):265-269. PubMed ID: 31109395
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, conformational characteristics and anti-influenza virus A activity of some 2-adamantylsubstituted azacycles.
Setaki D; Tataridis D; Stamatiou G; Kolocouris A; Foscolos GB; Fytas G; Kolocouris N; Padalko E; Neyts J; De Clercq E
Bioorg Chem; 2006 Oct; 34(5):248-73. PubMed ID: 16879857
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
Cheng H; Wan J; Lin MI; Liu Y; Lu X; Liu J; Xu Y; Chen J; Tu Z; Cheng YS; Ding K
J Med Chem; 2012 Mar; 55(5):2144-53. PubMed ID: 22332894
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of bioactive 1,2-annulated adamantane derivatives.
Zoidis G; Tsotinis A; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E
Org Biomol Chem; 2008 Sep; 6(17):3177-85. PubMed ID: 18698478
[TBL] [Abstract][Full Text] [Related]
17. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective synthesis of novel adamantane derivatives with high potency against rimantadine-resistant influenza A virus strains.
Kuznetsov NY; Tikhov RM; Godovikov IA; Medvedev MG; Lyssenko KA; Burtseva EI; Kirillova ES; Bubnov YN
Org Biomol Chem; 2017 Apr; 15(15):3152-3157. PubMed ID: 28338150
[TBL] [Abstract][Full Text] [Related]
19. Adamantylthiourea derivatives as antiviral agents.
Tilley JW; Levitan P; Kramer MJ
J Med Chem; 1979 Aug; 22(8):1009-10. PubMed ID: 490532
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiviral activities of adamantane spiro compounds. 1. Adamantane and analogous spiro-3'-pyrrolidines.
Lundahl K; Schut J; Schlatmann JL; Paerels GB; Peters A
J Med Chem; 1972 Feb; 15(2):129-32. PubMed ID: 4332673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
